Original Article
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 7, 2009; 15(45): 5654-5661
Published online Dec 7, 2009. doi: 10.3748/wjg.15.5654
Table 4 Change of abnormalities based on a 5-year follow-up among the subgroups stratified by ALT and shift work (%)
MetS and its componentse-ALT initiallypRSW exposureBaselineP value15th yrP value1Δ 5th yr vs baseline
Central obesityNoNo2.80.159522.20.003719.4
Yes3.220.016.8
YesNo5.933.627.7
Yes7.033.826.8
HyperglycemiaNoNo22.00.565816.7< 0.0001-5.2
Yes18.413.9-4.5
YesNo22.726.94.2
Yes18.333.815.5
HypertriglyceridemiaNoNo15.1< 0.000126.8< 0.000111.7
Yes13.225.512.3
YesNo34.542.07.6
Yes23.945.121.1
Elevated blood pressureNoNo18.30.0148.00.102529.6
Yes20.650.029.4
YesNo29.455.526.1
Yes31.062.031.0
Hypo-HDL cholesterolNoNo18.50.00186.3< 0.0001-12.3
Yes17.18.1-9.0
YesNo32.817.6-15.1
Yes23.923.90.0
Development of MetS within 5 yrNoNo11.1< 0.0001
Yes8.7
YesNo27.7
Yes36.6
MetS-component numbers (mode)NoNo010
Yes010
YesNo210
Yes121